Why Was Eskata Discontinued? Key Factors Behind the Withdrawal
•
4 min read
In 2019, just two years after its FDA approval, Eskata, a prescription medication for raised seborrheic keratoses, was voluntarily pulled from the U.S. market by its manufacturer. The withdrawal was driven by financial considerations, which is the central reason **why was Eskata discontinued**.
